BUY Fortis Healthcare — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Swing (≤2wk))18 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Jefferies Spots A New Growth Trigger For Max Healthcare, Fortis, Medanta In Delhi's 2047 Master Plan
NewsGoogle News·25 Aug · today
Fortis Healthcare shares gain 2.52%, trades at Rs 929.00
NewsGoogle News·14 Aug · 1w ago
Fortis Healthcare Q1 Review: Analysts Bullish Despite Short-Term Margin Pressure — Should You Buy?
NewsNdtv-Profit·10 Aug · 2w ago
Fortis Healthcare Q1 profit rises 2%; hospital revenue grows 19% on higher occupied beds
NewsCnbc-Tv18·6 Aug · 3w ago
Fortis Healthcare Q1 Results: Profit rises 2.3% to Rs 273 crore
NewsEt-Markets·6 Aug · 3w ago
Fortis Healthcare Success Story: Rise, Fall & Revival Explained
NewsGoogle News·22 Aug · 2d ago
Fortis Healthcare Share Price and Healthcare Sector View
NewsGoogle News·14 Aug · 1w ago
Fortis Healthcare Q1 Results: Profit Growth Muted As Margins Contract; Revenue Up 17%
NewsNdtv-Profit·6 Aug · 3w ago
Fortis Healthcare announced its Q1 FY27 financial results, reporting consolidated revenues of INR 2,545 Cr and operating EBITDA margin of 22.3%. The company also highlighted growth in its hospital and
NSE · Press Release·6 Aug · 3w ago
Fortis Healthcare Ltd has submitted a press release regarding its financial results for the quarter ended June 30, 2026, as per SEBI regulations. The document contains financial highlights and busines
BSE · Company Update·6 Aug · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Fortis Healthcare
- SELL — Manas Jaiswal14 Oct 2026 · ~2 weeks · target ₹660 · Active
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹950 · Active
- SELL — Mahesh Ojha, Kantilal Chhaganlal Securities27 Sept 2026 · ~2 weeks · target ₹820 · Target hit
- SELL — Manas Jaiswal25 Sept 2026 · ~2 weeks · target ₹825 · Target hit
- BUY — Nomura India Research7 Sept 2026 · ~1 year · target ₹1,030 · Active
More from Prakash Gaba
- SELL Kalyan Jewellers India23 Oct 2026 · ~2 weeks · target ₹510 · Target hit
- BUY Shilpa Medicare23 Oct 2026 · ~2 weeks · target ₹900 · SL hit
- SELL Ather Energy23 Oct 2026 · Same day · target ₹1,380 · Target hit
- BUY UltraTech Cement23 Oct 2026 · Same day · target ₹11,200 · SL hit
- BUY The Indian Hotels Company22 Oct 2026 · Next day · target ₹800 · SL hit

